140 results
Page 3 of 7
8-K
EX-10.1
h5vqc6 8nrd5a
2 Apr 21
Agios Announces Closing of Oncology Business Sale to Servier
4:47pm
8-K
EX-99.1
zbo5 6t2bgkiu
25 Feb 21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
7:17am
DEFM14A
ypxugdzjqeg
11 Feb 21
Proxy related to merger
4:19pm
PREM14A
zuyq0grwvcv5jf5t
29 Jan 21
Preliminary proxy related to merger
4:22pm
8-K
EX-99.1
s04h 0usixq
26 Jan 21
Other Events
4:14pm
DEFA14A
9bs5koy kxkavbd
12 Jan 21
Additional proxy soliciting materials
5:15pm
DEFA14A
6jnmpm
11 Jan 21
Additional proxy soliciting materials
7:17am
8-K
EX-99.1
chx uv4aas3ye7
11 Jan 21
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
7:14am
DEFA14A
1u1dt
23 Dec 20
Additional proxy soliciting materials
4:52pm
DEFA14A
EX-2.1
io9qg
21 Dec 20
Additional proxy soliciting materials
9:17pm
8-K
EX-2.1
dn5h35s yx1zk
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
DEFA14A
8q5qy3qcf
21 Dec 20
Additional proxy soliciting materials
5:23pm
DEFA14A
gfo50kihsxt wl1s
21 Dec 20
Additional proxy soliciting materials
5:21pm
8-K
EX-99.1
w299ys
7 Dec 20
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
4:53pm
8-K
EX-99.1
q8pcuksc0 biis665g4t
1 Dec 20
Other Events
7:46am
8-K
EX-99.1
tnqwq4
5 Nov 20
Agios Reports Business Highlights and Third Quarter 2020 Financial Results
7:32am
8-K
EX-99.1
dpy28m76ykbry9tyy2dn
21 Sep 20
Other Events
7:14am
8-K
EX-99.1
ze8ustmvfzstc62c
8 Sep 20
Agios Appoints Jonathan Biller as Chief Financial Officer, Head of Legal and Corporate Affairs
4:09pm